Literature DB >> 31084880

Terpenes in Cannabis sativa - From plant genome to humans.

Judith K Booth1, Jörg Bohlmann2.   

Abstract

Cannabis sativa (cannabis) produces a resin that is valued for its psychoactive and medicinal properties. Despite being the foundation of a multi-billion dollar global industry, scientific knowledge and research on cannabis is lagging behind compared to other high-value crops. This is largely due to legal restrictions that have prevented many researchers from studying cannabis, its products, and their effects in humans. Cannabis resin contains hundreds of different terpene and cannabinoid metabolites. Many of these metabolites have not been conclusively identified. Our understanding of the genomic and biosynthetic systems of these metabolites in cannabis, and the factors that affect their variability, is rudimentary. As a consequence, there is concern about lack of consistency with regard to the terpene and cannabinoid composition of different cannabis 'strains'. Likewise, claims of some of the medicinal properties attributed to cannabis metabolites would benefit from thorough scientific validation.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cannabinoids; Cannabis; Entourage effect; Specialized secondary metabolism; Standardization; Strains; Terpene synthase; Terpenes

Mesh:

Substances:

Year:  2019        PMID: 31084880     DOI: 10.1016/j.plantsci.2019.03.022

Source DB:  PubMed          Journal:  Plant Sci        ISSN: 0168-9452            Impact factor:   4.729


  33 in total

1.  Terpene Synthases and Terpene Variation in Cannabis sativa.

Authors:  Judith K Booth; Macaire M S Yuen; Sharon Jancsik; Lufiani L Madilao; Jonathan E Page; Jörg Bohlmann
Journal:  Plant Physiol       Date:  2020-06-26       Impact factor: 8.340

2.  Gene Networks Underlying Cannabinoid and Terpenoid Accumulation in Cannabis.

Authors:  Jordan J Zager; Iris Lange; Narayanan Srividya; Anthony Smith; B Markus Lange
Journal:  Plant Physiol       Date:  2019-05-28       Impact factor: 8.340

3.  Barriers to the wider adoption of medicinal Cannabis.

Authors:  Stephen Ph Alexander
Journal:  Br J Pain       Date:  2020-05-29

4.  Characteristics of Dispensary Patients that Limit Alcohol after Initiating Cannabis.

Authors:  Assad Hayat; Brian J Piper
Journal:  J Psychoactive Drugs       Date:  2019-12-07

Review 5.  Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain.

Authors:  Barbara Stella; Francesca Baratta; Carlo Della Pepa; Silvia Arpicco; Daniela Gastaldi; Franco Dosio
Journal:  Drugs       Date:  2021-09-04       Impact factor: 9.546

Review 6.  Acidic Cannabinoid Decarboxylation.

Authors:  Crist N Filer
Journal:  Cannabis Cannabinoid Res       Date:  2021-09-22

7.  The phytochemical diversity of commercial Cannabis in the United States.

Authors:  Christiana J Smith; Daniela Vergara; Brian Keegan; Nick Jikomes
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.752

8.  Odor Control in the Cannabis Industry: Lessons from the New Kid on the Block.

Authors:  Nate Seltenrich
Journal:  Environ Health Perspect       Date:  2022-06-27       Impact factor: 11.035

9.  Effects of steam sterilization on reduction of fungal colony forming units, cannabinoids and terpene levels in medical cannabis inflorescences.

Authors:  Shachar Jerushalmi; Marcel Maymon; Aviv Dombrovsky; Rafi Regev; Ze'ev Schmilovitch; Dvora Namdar; Nurit Shalev; Hinanit Koltai; Stanley Freeman
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

10.  Tetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2).

Authors:  Xin Chen; Jashvant D Unadkat; Qingcheng Mao
Journal:  Drug Metab Dispos       Date:  2021-07-29       Impact factor: 3.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.